University Hospital Bonn- Department of Nuclear Medicine

About The Hospital Departments Accommodation

University hospital Bonn

Bonn, Germany

( 8/10 from votes )

Head of the Department

Prof. Dr. Markus Essler

Department of Nuclear Medicine

Description Curriculum vitae

Department of Nuclear Medicine at University Hospital Bonn uses nuclear methods for the diagnosis and treatment of tumors and certain neurological and hormonal disorders. This department was established in 1951 and now, its work has been such a positive contribution that it’s a pioneer in its specialization in Germany. The department offers new and innovative treatment methods for the treatment of various cancers such as the Lutetium- 177 PSMA therapy for prostate cancer which improves the prognosis and can be used in more advanced stages than the previous therapies.
The department treats more than 800 inpatients every year under the leadership of Prof. Dr. Med. Markus Essler. Nuclear Medicine is known for its focus on thyroid diseases and this department has it as the main priority. The Thyroid Center of the Department of Nuclear Medicine is in cooperation with Radiology Center and has the medical staff which is specialized in the treatment of Graves’ disease, thyrotoxicosis, thyroid cancer and all types of thyroiditis.

Department of Nuclear Medicine at University Hospital Bonn is specialized in the diagnosis and treatment of:

•   Hot thyroid nodule
•   Cold thyroid nodule
•   Graves' disease
•   Goiter
•   Hashimoto's thyroiditis
•   Papillary thyroid carcinoma
•   Follicular thyroid carcinoma
•   Medullary thyroid carcinoma
•   De Quervain's thyroiditis
•   Lung tumors
•   Kidney tumors
•   Skeletal tumors
•   Prostate cancer
•   Bone metastases
•   Neuroendocrine tumors

Curriculum vitae of Prof. Dr. med. Markus Essler

Education and Professional Career

1989 - 1995 Study of Medicine at Ludwig Maximilian University of Munich.
09.11.1995 Medical examination.
1993 - 1996 Doctoral thesis defense at the Institute for the Prevention and Epidemiology of Hematopoietic Diseases, Muenster (under the direction of Prof. Dr. med. Peter K. Weber). Subject: "The role of Ras-like GTPases in the regulation of cytokinesis of myelomonocytic cells".
25.04.1996 Doctoral thesis defense with honors.
1996 - 2000 Research Fellow, Innenstadt Hospital, Ludwig Maximilian University of Munich.
2000 - 2002 Research Grant from the German Research Foundation, Burnham Institute, Cancer Research Center.
11.2001 Award from the US Department of Defense (breast cancer).
Since 07.2002 Research Fellow, Department of Nuclear Medicine, Rechts der Isar Hospital Munich (Head: Prof. Dr. med. Markus Schweiger).
15.11.2004 Ph.D. thesis defense and appointment to the position of PD in Clinical Pathophysiology at the Ludwig Maximilian University of Munich.
26.06.07 Medical Specialist in Nuclear Medicine and Professional Certification of the Bavarian Medical Association.
10.2007 Appointment to the position of W3 Professor of Nuclear Medicine, University Hospital Ulm (refusal).
06.2009 Position in the Department of Nuclear Medicine at the Hannover Medical School (Successor of Prof. Dr. med. W. Knapp), 2nd place on the list.
07.2010 Ph.D. thesis defense and appointment as PD at the Technical University of Munich.
11.2010 Appointment as the Clinical Senior Physician.
11.2010 Appointment as the Extraordinary Professor, Technical University of Munich.
06.2011 Invitation to the Department of Nuclear Medicine, University of Cologne (3rd place in the list).
12.2012 Invitation to the Department of Nuclear Medicine at the University of Vienna (2nd place in the list).
04.2013 Invitation to the Department of Nuclear Medicine (Successor of the Prof. Dr. med. V. A. Weber), 2nd place in the list.
05.2013 Invitation to the Department of Nuclear Medicine, University of Bonn.
Since 11.2013 Head of the Department of Nuclear Medicine at the University Hospital Bonn.

Additional Qualifications

2010 University Certification in Medical Didactics, Carl von Linde Institut, Munich.
2011 Healthcare Management Certification, Medical Association of North Rhine, MIBEG Institute, Cologne.

Publications

60 publications in international journals, including the review activities.
33 publications as the first and last "Corresponding Author".

Patents

Specific vascular peptide affiliated to breast tumors ("homing-peptide") for the administration of drugs into the breast tissue in precancerous conditions.
2003 Modifications of non-fibrillar collagen in tumor blood vessels and substances tropic to it.
2008 Peptides, which are specifically connected to a modified matrix metalloproteinase that breaks down collagen (registered model 20
2008 012716.59)
2013 Bi-213 labeled antibodies to the CD38 antigen in the treatment of multiple myeloma.

Memberships in Professional Societies